Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
8-K
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
Elevance Health is one of the largest health insurers in the United States, operating Blue Cross Blue Shield branded health plans across multiple states, along with Carelon, a growing healthcare services and pharmacy benefit management business.
Business model
The company earns premium revenue from health insurance plans across commercial, Medicare, and Medicaid segments, supplemented by fee revenue from its Carelon healthcare services businesses which provide diversification beyond core insurance underwriting.
Growth drivers
- Medicare Advantage membership growth
- Carelon healthcare services and pharmacy benefit expansion
- Medical cost management improvements
- Government program contract retention and growth
Competitive position
Elevance Health's Blue Cross Blue Shield brand licenses in its core states, combined with its scale in government sponsored health programs, give it a strong position in a consolidated health insurance industry with significant barriers to entry.
Risks
Medical cost trend increases can pressure margins if pricing does not keep pace, government program reimbursement rate changes directly affect profitability, and regulatory scrutiny of the health insurance industry remains ongoing.
Valuation
Elevance Health trades at a moderate multiple typical of large health insurers, with the market closely watching medical cost trend developments as the primary driver of near term earnings.
Final view
Elevance Health's diversification into healthcare services through Carelon provides a growth avenue beyond core insurance underwriting. My view is neutral to favorable, with medical cost trend management being the key factor to monitor.
Overall rating: 64/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.